In the BioHarmony Drug Report Database

"Preview" Icon

Interferon gamma-1b

Actimmune, Betaferon, Extavia (interferon gamma-1b) is a protein pharmaceutical. Interferon gamma-1b was first approved as Actimmune on 1995-11-30. It is used to treat bacterial infections, brain neoplasms, chronic hepatitis c, colorectal neoplasms, and cryoglobulinemia amongst others in the USA. It has been approved in Europe to treat multiple sclerosis.

 

Trade Name

 

Betaferon, Extavia
 

Common Name

 

interferon gamma-1b
 

ChEMBL ID

 

CHEMBL1201564
 

Indication

 

bacterial infections, brain neoplasms, chronic hepatitis c, colorectal neoplasms, cryoglobulinemia, essential thrombocythemia, hairy cell leukemia, hemangioma, hepatitis d, hepatocellular carcinoma, hypereosinophilic syndrome, ileal neoplasms, kaposi sarcoma, macular degeneration, melanoma, multiple myeloma, multiple sclerosis, mycosis fungoides, osteopetrosis, renal cell carcinoma, sezary syndrome, skin neoplasms, skin ulcer, thrombocytopenia, warts
 

Drug Class

 

Image (chem structure or protein)

Interferon gamma-1b structure rendering